Centerpoint Advisors’s Danimer Scientific, Inc. DNMR Stock Holding History

Centerpoint Advisors’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13	Closed	-$1K	–	538
2022 Q3	$1K	Hold	13	–	–	﹤0.01%	378
2022 Q2	$2K	Hold	13	–	–	﹤0.01%	337
2022 Q1	$3K	Hold	13	–	–	﹤0.01%	310
2021 Q4	$4K	Hold	13	–	–	﹤0.01%	299
2021 Q3	$8K	Buy	+13	New	+$9.56K	﹤0.01%	213

Other funds holding DNMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Centerpoint Advisors's DNMR Position: Q4 2022 in Review

Centerpoint Advisors sold out of Danimer Scientific, Inc. (DNMR) in Q4 2022, closing a stake of 13 shares — an estimated $1K sold.

Centerpoint Advisors first reported a position in DNMR in Q3 2021 and held it in 5 quarters. The position peaked at $8K in Q3 2021. 176 funds tracked by Wall St. Rank hold DNMR as of Q4 2022.

Centerpoint Advisors reported no remaining Danimer Scientific, Inc. position as of Q4 2022 after selling out during the quarter.
Centerpoint Advisors sold 13 Danimer Scientific, Inc. shares in Q4 2022, an estimated $1K.
Centerpoint Advisors first reported a position in Danimer Scientific, Inc. in Q3 2021 and held it in 5 quarters.
Centerpoint Advisors's Danimer Scientific, Inc. position peaked at $8K in Q3 2021.
176 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2022.

Based on Centerpoint Advisors's 13F filing for Q4 2022, filed 24 Jan 2023.